OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
18 hedge funds and large institutions have $4.6M invested in OncoSec Medical Incorporated in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 1 closing their positions.
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
50% more funds holding
Funds holding: 12 → 18 (+6)
19% less capital invested
Capital invested by funds: $5.67M → $4.6M (-$1.07M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.25M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$340K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$91.8K |
| 4 |
Bank of New York Mellon
New York
|
+$77.3K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$66.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.55M |
| 2 |
Morgan Stanley
New York
|
-$256K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$128K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21K |
| 5 |
W
Wealthfront
Palo Alto,
California
|
-$1K |
ONCS Hedge Fund Activity: Q3 2015 in Review
18 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2015, worth a combined $4.6M — down 19% from $5.67M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ONCS positions and 1 closed out — a net gain of 6 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $2.25M. The largest seller was Sabby Management, cutting an estimated $2.55M.
- 18 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2015, up from 12 in Q2 2015.
- Funds reported $4.6M of OncoSec Medical Incorporated stock for Q3 2015, down 19% quarter-over-quarter.
- 7 funds opened new OncoSec Medical Incorporated positions in Q3 2015 and 1 closed out, a net change of +6 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2015 was Vanguard Group, an estimated $2.25M added.
- The largest OncoSec Medical Incorporated seller in Q3 2015 was Sabby Management, an estimated $2.55M sold.
Based on aggregated 13F filings for Q3 2015.